Effect of homeopathic Lycopodium clavatum on memory functions and cerebral blood flow in memory-impaired rats^{[ # ]}

Background: Lycopodium clavatum (Lyc) is a widely used homeopathic medicine for the liver, urinary and digestive disorders. Recently, acetyl cholinesterase (AchE) inhibitory activity has been found in Lyc alkaloid extract, which could be beneficial in dementia disorder. However, the effect of Lyc has not yet been explored in animal model of memory impairment and on cerebral blood flow.

Aim: The present study was planned to explore the effect of Lyc on learning and memory function and cerebral blood flow (CBF) in intracerebroventricularly (ICV) administered streptozotocin (STZ) induced memory impairment in rats.

Materials and methods: Memory deficit was induced by ICV administration of STZ (3 mg/kg) in rats on 1st and 3rd day. Male SD rats were treated with Lyc Mother Tincture (MT) 30, 200 and 1000 for 17 days. Learning and memory was evaluated by Morris water maze test on 14th, 15th and 16th day. CBF was measured by Laser Doppler flow meter on 17th day.

Results: STZ (ICV) treated rats showed impairment in learning and memory along with reduced CBF. Lyc MT and 200 showed improvement in learning and memory. There was increased CBF in STZ (ICV) treated rats at all the potencies of Lyc studied.

Conclusion: The above study suggests that Lyc may be used as a drug of choice in condition of memory impairment due to its beneficial effect on CBF.

Keywords

Lycopodium clavatum - Cerebral blood flow - Streptozotocin - Cognitive dysfunction

• References

• 1 Ajmani R.S., Metter E.J., Jaykumar R. et al. Hemodynamic changes during aging associated with cerebral blood flow and impaired cognitive function. Neurobiol Aging 2000; 21: 257-269.
• 2 Saxena G., Bharti S., Kamat P.K., Sharma S., Nath C. Melatonin alleviates memory deficits and neuronal degeneration induced by intracerebroventricular administration of streptozotocin in rats. Pharmacol Biochem Behav 2010; 94: 397-403.
• 3 Awasthi H., Tota S., Hanif K., Nath C., Shukla R. Protective effect of Curcumin against intracerebral streptozotocin induced impairment in memory and cerebral blood flow. Life Sci 2010; 86: 87-94.
• 4 Tota S., Awasthi H., Kamat P.K., Nath C., Hanif K. Protective effect of against intracerebral streptozotocin induced reduction in cerebral blood flow and impairment of memory in mice. Behav Brain Res 2010; 209: 73-79.
• 5 Yang L., Ye C.Y., Huang X.T., Tang X.C., Zhang H.Y. Decreased accumulation of subcellular amyloid-β with improved mitochondrial function mediates the neuroprotective effect of huperzine. J Alzheimers Dis 2012; 31 (01) 131-142.
• 6 Anonymous. The useful plants of India, Publication and Information Directorate . CSIR; New Delhi: 1992: 342-343.
• 7 Calderσn A.I., Simithy-Williams J., Sanchez R., Espinosa A., Valdespino I., Gupta M.P. Lycopodiaceae from Panama: a new source of acetylcholinesterase inhibitors. Nat Prod Res 2013; 27 4–5 500-505.
• 8 Reale M., Iarlori C., Gambi F., Feliciani C., Isabella L., Gambi D. The acetylcholinesterase inhibitor, Donepezil, regulates a Th2 bias in Alzheimer's disease patients. Neuropharmacology 2006; 50 (05) 606-613.
• 9 Tota S., Kamat P.K., Shukla R., Nath C. Improvement of brain energy metabolism and cholinergic functions contributes to the beneficial effects of silibinin against streptozotocin induced memory impairment. Behav Brain Res 2011; 221 (01) 207-215.
• 10 Paxinos G., Watson C.R., Emson P.C. AChE-stained horizontal sections of the rat brain in stereotaxic coordinates. J Neurosci Methods 1980; 3 (02) 129-149.
• 11 Lannert H., Hoyer S. Intracerebroventricular administration of streptozotocin causes long-term diminutions in learning and memory abilities and in cerebral energy metabolism in adult rats. Behav Neurosci 1998; 112: 1199-1208.
• 12 Morris R. Developments of a water-maze procedure for studying spatial learning in the rat. J Neurosci Methods 1984; 11: 47-60.
• 13 Tota S., Kamat P.K., Awasthi H., Singh N., Raghubir R., Nath C. Candesartan improves memory decline in mice: involvement of AT1 receptors in memory deficit induced by intracerebral streptozotocin. Behav Brain Res 2009; 199: 235-240.
• 14 Kamat P.K., Tota S., Rai S. Okadaic acid induced neurotoxicity leads to central cholinergic dysfunction in rats. Eur J Pharmacol 2012; 690 1–3 90-98.
• 15 Kaduszkiewicz H., Zimmermann T., Beck-Bornholdt H.P., van den Bussche H. Cholinesterase inhibitors for patients with Alzheimer's disease: systematic review of randomised clinical trials. BMJ 2005; 331 7512 321-327.
• 16 Tota S., Nath C., Najmi A.K., Shukla R., Hanif K. Inhibition of central angiotensin converting enzyme ameliorates scopolamine induced memory impairment in mice: role of cholinergic neurotransmission, cerebral blood flow and brain energy metabolism. Behav Brain Res 2012; 232 (01) 66-76.
• 17 Crawford J.G. Alzheimer's disease risk factors as related to cerebral blood flow. Med Hypotheses 1996; 46: 367-377.
• 18 O'Brien J.T., Eagger S., Syed G.M., Sahakian B.J., Levy R. A study of regional cerebral blood flow and cognitive performance in Alzheimer's disease. J Neurol Neurosurg Psychiatry 1992; 55: 1182-1187.
• 19 Prohovnik I., Mayeux R., Sackeim H.A., Smith G., Stern Y., Alderson P.O. Cerebral perfusion as a diagnostic marker of early Alzheimer's disease. Neurology 1988; 38: 931-937.
• 20 Tota S., Goel R., Pachauri S.D., Najmi A.K., Hanif K., Nath C. Effect of angiotensin II on spatial memory, cerebral blood flow, cholinergic neurotransmission, and brain derived neurotrophic factor in rats. Psychopharmacol Berl 2013; 226 (02) 357-369.